Comorbid condition in patients with psoriasis
S.V. BATYRSHINA1, F.G. SADYKOVA2
¹Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation, 420012
2Republican Clinical Dermatovenereology Dispensary, 4 Tolstoy St., Kazan, Russian Federation, 420012
Batyrshina S.V. — D. Med. Sc., Professor of the Department of Dermatology and Venereology, tel. (843) 236-99-92, e-mail: sbkdv @ mail. ru
Sadykova F.G. — Head of the In-patient Department № 2, tel. (843) 236-09-04, e-mail: f.sadukova@tatar.ru
The article describes the modern literature and own data on the connection of psoriasis with various somatic diseases. It identifies the most frequent comorbid diseases recorded in patients, depending on the severity of psoriasis, as well as the methods used to assess comorbidity. It is proposed to consider the real possibility of a somatic disease in patients with psoriasis, and change their survey program to confirm / exclude such disease.
Key words: psoriasis, comorbidity.
REFERENCES
1. Badokin V.V. Psoriaticheskiy artrit: klinika, diagnostika, lechenie: avtoref. diss. …d. m. n [Psoriatic arthritis: clinical features, diagnosis, treatment. Synopsis of dis. Dr med. sci]. Moscow, 2003. 32 p.
2. Madland T.M., Apalset E.M., Johanntnssen A.E. et al. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J. Rheumatol., 2005, vol. 32, rr. 1918-22.
3. Zachariae H., Zachariae R., Blomqvist K. et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venerol., 2002, vol. 82, rr. 108-13.
4. Rukavishnikova V.M. Mikozy stop [Tinea pedis]. Moscow, 1999. 317 p.
5. Reznikova M.M., Trofimova I.B., Korsunskaya I.M. et al. Mycotic infection in patients with psoriasis clinical. Klinich. derm. i vener., 2009, no. 3, pp. 22-24 (in Russ.).
6. Mordovtsev V.N., Sergeev A.S., Alieva P.M., Koshechkin V.A. The association of psoriasis with hyperlipidaemia, stroke, coronary heart disease, myocardial infarction and diabetes. Vestn. dermatol., 1982, no. 9, pp. 4-8 (in Russ.).
7. Yanysheva A.V. Metabolic abnormalities in psoriatic arthritis. Sibirskiy med. Zhurn., 2009, no. 2, pp. 25-28 (in Russ.).
8. DCCT Research Group Reliability and validity of a diabetes quality of life measure for the diabetes control and complications trial (DCCT). Diabetes Care, 1998, vol. 11, rr. 725-732.
9. Michelson H., Bolund C., Brandberg Y. Multiple chronic health problems are negatively associated with health related quality of life (HRQOL) irrespective of age. Qual Life Res., 2000, vol. 9, rr. 1093-1104.
10. Starfield B., Lemke K.W., Bernhardt T. Comorbidity: Implications for the Importance of Primary Care in Case Management. Ann Fam Med., 2003, vol. 1 (1), rr. 8-14.
11. Sommer D.M., Jenisch S., Suchan M., Christophers E. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch. Dermatol. Res., 2006, vol. 298 (7), rr. 321-328.
12. van Weel C., Schellevis F.G. Comorbidity and guidelines: conflicting interest. Lancet, 2006, vol. 367, rr. 550-551.
13. Shapiro J., Cohen A.D., David M., Hodak E. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a casecontrol study. J. Am. Acad. Dermatol., 2007, vol. 56 (4), rr. 629-6934.
14. Gottlieb A.B., Chao C., Dann F. Psoriasis comorbidities. J. Dermatolog Treat., 2008, vol. 19 (1), rr. 5-21.
15. Guenther L., Gulliver W. Psoriasis comorbidities. J. Cutan Med. Surg., 2009, vol. 13 (2), rr. 77-87.
16. Aurangabadkar S.J. Comorbidities in psoriasis. Indian J. Dermatol Venereol Leprol., 2013, vol. 79 (7), rr. 10-17.
17. Yeung H., Takeshita J., Mehta N.N. et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol., 2013, vol. 149 (10), rr. 1173-9.
18. Cardiovascular psoriasis comorbidities, treatment with atorvastatin. J. of the American Academy of Dermatology, 2014, vol. 70 (1), rr. 165-175.
19. Gill T., Feinstein A.R. A critical appraisal of the quality-of-life measurements. JAMA, 1994, vol. 272, rr. 619-626.